Halberd Corporation (OTCMKTS:HALB) Demonstrates Precise Control of Key Cancer Related T-Cell Protein
Over the course of the year so far Halberd Corporation (OTCMKTS:HALB) has emerged as one of the more interesting companies for the sort of research that it has conducted with regard to a wide range of ailments. The company was in the news yesterday after it made an announcement with regards to one of its latest research efforts. The company announced that its researchers had been successful in demonstrating the…